20 LATEST RESOURCES (425 INDEXED)
×
Efficacy and Safety of Zuranolone Co-Initiated with an Antidepressant in Adults with Major Depressive Disorder: Results from the Phase 3 CORAL Study · October 2023
Articles
Neuropsychopharmacology
×
Transdiagnostic Subgroups of Cognitive Impairment in Early Affective and Psychotic Illness · September 2023
Articles
Neuropsychopharmacology
×
Novel Neurosteroid Therapeutics for Post-Partum Depression: Perspectives on Clinical Trials, Program Development, Active Research, and Future Directions · September 2023
Articles
Neuropsychopharmacology
×
Clinical Response to EPA Supplementation in Patients with Major Depressive Disorder Is Associated with Higher Plasma Concentrations of Pro-Resolving Lipid Mediators · January 2023
Articles
Neuropsychopharmacology
×
Does Cannabidiol Make Cannabis Safer? A Randomised, Double-Blind, Cross-Over Trial of Cannabis with Four Different CBD:THC Ratios · November 2022
Articles
Neuropsychopharmacology
×
Interactive Relationships of Type 2 Diabetes and Bipolar Disorder with Cognition: Evidence of Putative Premature Cognitive Ageing in the UK Biobank Cohort · October 2022
Articles
Neuropsychopharmacology
×
Neuroimaging in Schizophrenia: An Overview of Findings and Their Implications for Synaptic Changes · September 2022
Articles
Neuropsychopharmacology
×
A Randomized Double-Blind, Placebo-Controlled Pilot Trial of Mirtazapine for Anxiety in Children and Adolescents with Autism Spectrum Disorder · March 2022
Articles
Neuropsychopharmacology
×
Direct Comparison of the Acute Effects of Lysergic Acid Diethylamide and Psilocybin in a Double-Blind Placebo-Controlled Study in Healthy Subjects · February 2022
Articles
Neuropsychopharmacology
×
Melatonergic Agents Influence the Sleep-Wake and Circadian Rhythms in Healthy and Psychiatric Participants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · February 2022
Articles
Neuropsychopharmacology
×
Large-Scale Structural Network Change Correlates with Clinical Response to rTMS in Depression · February 2022
Articles
Neuropsychopharmacology
×
Common and Specific Large-Scale Brain Changes in Major Depressive Disorder, Anxiety Disorders, and Chronic Pain: A Transdiagnostic Multimodal Meta-Analysis of Structural and Functional MRI Studies · January 2022
Articles
Neuropsychopharmacology
×
EEG Reveals that Dextroamphetamine Improves Cognitive Control through Multiple Processes in Healthy Participants · January 2022
Articles
Neuropsychopharmacology
×
White-Matter Free-Water Diffusion MRI in Schizophrenia: A Systematic Review and Meta-Analysis · January 2022
Articles
Neuropsychopharmacology
×
Associations of Risk Genes with Onset Age and Plasma Biomarkers of Alzheimer’s Disease: A Large Case–Control Study in Mainland China · January 2022
Articles
Neuropsychopharmacology
×
Benzodiazepine Use and Neuroimaging Markers of Alzheimer’s Disease in Nondemented Older Individuals: An MRI and 18F Florbetapir PET Study in the MEMENTO Cohort · December 2021
Articles
Neuropsychopharmacology
×
Insulin and Glucose Metabolism with Olanzapine and a Combination of Olanzapine and Samidorphan: Exploratory Phase 1 Results in Healthy Volunteers · December 2021
Articles
Neuropsychopharmacology
×
Intranasal Oxytocin Administration Impacts the Acquisition and Consolidation of Trauma-Associated Memories: A Double-Blind Randomized Placebo-Controlled Experimental Study in Healthy Women · December 2021
Articles
Neuropsychopharmacology
×
Rapid-Acting Antidepressants and the Circadian Clock · November 2021
Articles
Neuropsychopharmacology